Literature DB >> 8495974

Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway.

F Q Cunha1, D W Moss, L M Leal, S Moncada, F Y Liew.   

Abstract

Murine peritoneal macrophages stimulated in vitro with killed Gram-positive bacteria Staphylococcus aureus or its membrane components in the presence of interferon-gamma (IFN-gamma) expressed high levels of nitric oxide (NO) synthase and produced large amounts of NO in a dose-dependent manner. This is not due to the contamination by Gram-negative endotoxin because the stimulatory activity was not affected by the addition of polymyxin B. The expression of the NO synthase and the synthesis of NO by macrophages stimulated with toxic shock syndrome toxin-1 (TSST), lipoteichoic acid (LTA) or killed whole S. aureus together with IFN-gamma was inhibited by the glucocorticoid, dexamethasone or by the specific inhibitor of NO synthesis, L-N-iminoethyl-ornithine (L-NIO). The exotoxins together with IFN-gamma also activated macrophages to kill the intracellular parasite Leishmania major. The leishmanicidal activity was completely inhibited by L-NIO.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495974      PMCID: PMC1421893     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Staphylococcal exotoxins stimulate nitric oxide-dependent murine macrophage tumoricidal activity.

Authors:  D J Fast; B J Shannon; M J Herriott; M J Kennedy; J A Rummage; R W Leu
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

Authors:  D J Stuehr; M A Marletta
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

3.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; R K Hickman; D D Eardley; G B Pier
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

6.  Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.

Authors:  F Y Liew; J G Howard; C Hale
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

Review 7.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  Protective and pathological roles of nitric oxide in endotoxin shock.

Authors:  C E Wright; D D Rees; S Moncada
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

10.  T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.

Authors:  T Miethke; C Wahl; K Heeg; B Echtenacher; P H Krammer; H Wagner
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  16 in total

1.  Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.

Authors:  B Dassy; J M Fournier
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa.

Authors:  Michael T Borchers; Nathaniel L Harris; Scott C Wesselkamper; Shiping Zhang; Yi Chen; Lisa Young; Gee W Lau
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Loss of autophagy enhances MIF/macrophage migration inhibitory factor release by macrophages.

Authors:  Jacinta P W Lee; Andrew Foote; Huapeng Fan; Celia Peral de Castro; Tali Lang; Sarah A Jones; Nichita Gavrilescu; Kingston H G Mills; Michelle Leech; Eric F Morand; James Harris
Journal:  Autophagy       Date:  2016-05-10       Impact factor: 16.016

4.  Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse.

Authors:  D D Rees; F Q Cunha; J Assreuy; A G Herman; S Moncada
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

5.  Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock.

Authors:  K M Kengatharan; S J De Kimpe; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

6.  Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages.

Authors:  M Kengatharan; S J De Kimpe; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 7.  Nitric oxide: a synchronizing chemical messenger.

Authors:  M Anbar
Journal:  Experientia       Date:  1995-06-14

8.  Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.

Authors:  K Akarid; M Sinet; B Desforges; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets.

Authors:  E Villamor; F Pérez-Vizcaíno; T Ruiz; J C Leza; M Moro; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

10.  Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.

Authors:  S J De Kimpe; M L Hunter; C E Bryant; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.